Literature DB >> 19339332

Mental health services use and symptom prevalence in a cohort of adults on probation.

John F Crilly1, Eric D Caine, J Steven Lamberti, Theodore Brown, Bruce Friedman.   

Abstract

OBJECTIVE: This study examined the prevalence of mental disorder symptoms among adult probationers and the probability of mental health service use.
METHODS: Data from the 2001 National Household Survey on Drug Abuse were used to obtain information on adults reporting mental disorder symptoms who had been on probation within the past year and those who had not.
RESULTS: Twenty-seven percent of probationers (N=311 of 1,168) and 17% of nonprobationers (N=5,830 of 34,230) had mental disorder symptoms. Mental health service use was reported by 23% of both groups. Compared with persons who had not been on probation, probationers were more likely to report psychosis, mania, and posttraumatic stress disorder; both groups were as likely to report depression.
CONCLUSIONS: The prevalence of mental disorder symptoms did not differ by probation status. However, the type and distribution of symptoms were significantly different in the two groups. These are important considerations when planning for service connection with mental health providers.

Entities:  

Mesh:

Year:  2009        PMID: 19339332     DOI: 10.1176/ps.2009.60.4.542

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  10 in total

1.  The association between criminal history and mental health service use among people with serious mental illness.

Authors:  Jason Matejkowski; Sungkyu Lee; Woojae Han
Journal:  Psychiatr Q       Date:  2014-03

2.  Suicide risk and mental health co-morbidities in a probationer population.

Authors:  Roberto Cardarelli; Elizabeth Balyakina; Kendra Malone; Kimberly G Fulda; Michael Ellison; Ron Sivernell; Tanjina Shabu
Journal:  Community Ment Health J       Date:  2014-07-29

3.  The role of probation in forensic assertive community treatment.

Authors:  J Steven Lamberti; Alison Deem; Robert L Weisman; Casey LaDuke
Journal:  Psychiatr Serv       Date:  2011-04       Impact factor: 3.084

4.  Translating Interventions that Target Criminogenic Risk Factors for use in Community Based Mental Health Settings.

Authors:  Amy Blank Wilson; Natalie Bonfine; Kathleen J Farkas; Janelle Duda-Banwar
Journal:  Community Ment Health J       Date:  2017-02-24

5.  Expedited Medicaid Enrollment, Mental Health Service Use, and Criminal Recidivism Among Released Prisoners With Severe Mental Illness.

Authors:  Joseph P Morrissey; Marisa E Domino; Gary S Cuddeback
Journal:  Psychiatr Serv       Date:  2016-03-15       Impact factor: 3.084

6.  Using actor-partner interdependence modeling to understand recent illicit opioid use and injection drug use among men in community supervision and their female partners in New York City.

Authors:  Alissa Davis; Andrea Norcini Pala; Louisa Gilbert; Phillip L Marotta; Dawn Goddard-Eckrich; Nabila El-Bassel
Journal:  Int J Drug Policy       Date:  2020-07-09

7.  Statewide mental health training for probation officers: improving knowledge and decreasing stigma.

Authors:  Nikhil Tomar; Marilyn A Ghezzi; Lauren Brinkley-Rubinstein; Amy Blank Wilson; Tonya B Van Deinse; Stacey Burgin; Gary S Cuddeback
Journal:  Health Justice       Date:  2017-11-15

8.  Using the Consolidated Framework for Implementation Research to examine implementation determinants of specialty mental health probation.

Authors:  Tonya B Van Deinse; Alicia Bunger; Stacey Burgin; Amy Blank Wilson; Gary S Cuddeback
Journal:  Health Justice       Date:  2019-12-05

9.  Probation Officers' and Supervisors' Perspectives on Critical Resources for Implementing Specialty Mental Health Probation.

Authors:  Tonya B Van Deinse; Erika L Crable; Charlotte Dunn; Jessamyn Weis; Gary Cuddeback
Journal:  Adm Policy Ment Health       Date:  2020-09-14

10.  Mental Health Assessment of South Korean Adults on Probation.

Authors:  Soungwan Kim; Bongseog Kim
Journal:  Psychiatry Investig       Date:  2017-11-07       Impact factor: 2.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.